Hysteroscopy and ART: Defying Clinical Indications Based on Current Evidence
Surgery and Clinical Practice · 2024
DOI: 10.33425/3066-6538.1008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgery and Clinical Practice, 2024. Verfasst von Fani Gkrozou und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Embryo’s Implantation is a question that we are not in the position to answer in full details. We know that it depends on embryo’s quality and uterine receptivity. It is possible to access uterine cavity before in vitro fertilisation by a variety of tools, however hysteroscopy is the gold standard in evaluation of uterine cavity and potential pathology. The frequencies of unrecognised uterine pathology revealed by hysteroscopy are 18-50% and 40-43% in patients undergoing in vitro fertilisation or after recurrent implantation failure respectively. Data is inconclusive regarding the role of hysteroscopy on pregnancy outcome after ART. This review aims to evaluate the validity of office hysteroscopy in subfertile population before or after at least one failed fertility treatment.
Zitieren
APA
Gkrozou, F., Bouras-Soulimas, D., Bais, V., Koutalia, N., Lentzaris, D., Vatopoulou, A., Skentou, C., Paschopoulos, M., & Daniilidis, A. (2024). Hysteroscopy and ART: Defying Clinical Indications Based on Current Evidence. Surgery and Clinical Practice. https://doi.org/10.33425/3066-6538.1008
Vancouver
Gkrozou F, Bouras-Soulimas D, Bais V, Koutalia N, Lentzaris D, Vatopoulou A, et al. Hysteroscopy and ART: Defying Clinical Indications Based on Current Evidence. Surgery and Clinical Practice. 2024. doi:10.33425/3066-6538.1008
BibTeX
@article{Gkrozou2024,
author = {Gkrozou, Fani and Bouras-Soulimas, Dimitrios and Bais, Vasileios and Koutalia, Nikoleta and Lentzaris, Dimitrios and Vatopoulou, Anastasia and Skentou, Chara and Paschopoulos, Minas and Daniilidis, Angelos},
title = {Hysteroscopy and ART: Defying Clinical Indications Based on Current Evidence},
journal = {Surgery and Clinical Practice},
year = {2024},
doi = {10.33425/3066-6538.1008}
}
EUVIMED